View Information Collection Request (ICR) Package

OMB Control No: 0920-1273	ICR Reference No: 202211-0920-018
Status: Historical Active	Previous ICR Reference No: 202207-0920-006
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-1273
Title: Pregnancy Risk Assessment Monitoring System (PRAMS)
Type of Information Collection: Revision of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 03/30/2023
Retrieve Notice of Action (NOA)	Date Received in OIRA: 11/30/2022
Terms of Clearance: Cleared consistent with the understanding that the program will: 1) submit a non-substantive change request to OMB to upload to ROCIS the final version of its cognitive testing within 60 days; 2) submit a further non-substantive change request to OMB upon the completion of its nonresponse bias analysis on the 2020 data, requesting approval for any changes in its data dissemination policy; and 3) continue to work with the jurisdictions to ensure that incentives are based on empirical analysis of reduction in non-response bias and as consistent as possible across jurisdictions to avoid creating the expectation that federal surveys typically provide incentives for participation.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	03/31/2026	36 Months From Approved	03/31/2023
Responses	108,240	0	149,094
Time Burden (Hours)	31,268	0	33,641
Cost Burden (Dollars)	0	0	825,520

Abstract: The Pregnancy Risk Assessment Monitoring System (PRAMS) collects state-, territory-, and tribal-specific information on maternal experiences and behaviors that occur before, during and shortly after pregnancy. Self-reported survey data are collected by mixed mode methods (mailing, web, telephone calls). Data collection procedures and instruments are standardized to allow comparison across jurisdictions. Data are used to inform maternal and infant health programs and policy to reduce maternal and infant morbidity and mortality. Data is used to monitor prevalence of behaviors and progress toward various targets (e.g., Healthy People 2020, Title V performance indicators, Healthy Start evaluation). This Revision includes 2 supplemental modules related to COVID-19: a 15-question supplement on COVID-19 related experiences and a 6-question supplement on experiences related to COVID-19 vaccination during pregnancy. These modules were initially approved for cognitive testing and data collection under the COVID-19 Public Health Emergency (PHE) Paperwork Reduction Act (PRA) waiver. With the anticipated end of the public health emergency declaration, CDC requests approval for continued data collection for 2022 births, incorporating the items needed for continued monitoring of COVID-19 vaccination and experiences, and expanded use of a web-based mode of data collection.

Authorizing Statute(s): PL: Pub.L. 109 - 450 3 Name of Law: PREEMIE Act
   US Code: 42 USC 301 Name of Law: Public Health Service Act: Research and Investigations
   US Code: 42 USC 247b-12 Name of Law: Safe Motherhood and Infant Health

Citations for New Statutory Requirements: None

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	87 FR 39837	07/05/2022
30-day Notice:	Federal Register Citation:	Citation Date:
	87 FR 69024	11/17/2022
Did the Agency receive public comments on this ICR? Yes

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion
Annual Number of Responses	108,240	149,094	-40,854
Annual Time Burden (Hours)	31,268	33,641	-2,373
Annual Cost Burden (Dollars)	0	825,520	-825,520

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: CDC will continue to use the approved Phase 8 questionnaires until April 2023, when the Phase 9 questionnaires will be implemented with changes in content that are described in an attachment to the ICR. Five states are currently implementing a web-based mode of data collection which will be made available as an option for all states in Phase 9. CDC has added a new IC to account for the burden to states of preparing and submitting an aggregate data file. There are minor changes to the estimated number of respondents for the core PRAMS survey, an expected increase in the use of supplemental modules, and updated estimates for field testing. Additional information collection needed to monitor COVID-19 vaccination and experiences was formally incorporated in 2022 and will continue. The net result is a modest decrease in total estimated annualized burden of 2,373 hours. In addition, note that the change in the total cost burden appears to be very large. However, the change in total cost burden is associated with the change in accounting method. In the past, CDC reported the cost burden for each IC as the wage-equivalents that appear in Section 12.B of the supporting statement. Consistent with the rest of HHS, CDC is now reporting the total from Section 13 in the "burden cost" field for each IC. Section 13 covers nonwage costs (e.g., equipment). As such, costs associated with these ICs are now "zero."

Annual Cost to Federal Government: $7,025,000

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Yes

Agency Contact: Renita Macaluso 770 488-6458 arp5@cdc.gov

View ICR - OIRA Conclusion